Author: ALLISON GATLIN
Source
Cytokinetics said Monday its drug “significantly” improved exercise capacity in HCM patients. But Cytokinetics stock slipped Monday.
The post Cytokinetics Reveals More From The Study That Boosted Shares 83% In A Day appeared first on Investor’s Business Daily.